A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer [Ann Oncol (2015), 26, 1923-1929]

B. H. O'Neil, A. J. Scott, W. W. Ma, S. J. Cohen, L. Leichman, D. L. Aisner, A. R. Menter, M. A. Tejani, J. K. Cho, J. Granfortuna, L. Coveler, O. O. Olowokure, J. C. Baranda, M. Cusnir, P. Phillip, J. Boles, R. Nazemzadeh, M. Rarick, D. J. Cohen, J. RadfordL. Fehrenbacher, R. Bajaj, V. Bathini, P. Fanta, J. Berlin, A. J. McRee, R. Maguire, F. Wilhelm, M. Maniar, A. Jimeno, C. L. Gomes, W. A. Messersmith

Research output: Contribution to journalArticle

5 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)2505
Number of pages1
JournalAnnals of Oncology
Volume26
Issue number12
DOIs
StatePublished - Dec 1 2015

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer [Ann Oncol (2015), 26, 1923-1929]. / O'Neil, B. H.; Scott, A. J.; Ma, W. W.; Cohen, S. J.; Leichman, L.; Aisner, D. L.; Menter, A. R.; Tejani, M. A.; Cho, J. K.; Granfortuna, J.; Coveler, L.; Olowokure, O. O.; Baranda, J. C.; Cusnir, M.; Phillip, P.; Boles, J.; Nazemzadeh, R.; Rarick, M.; Cohen, D. J.; Radford, J.; Fehrenbacher, L.; Bajaj, R.; Bathini, V.; Fanta, P.; Berlin, J.; McRee, A. J.; Maguire, R.; Wilhelm, F.; Maniar, M.; Jimeno, A.; Gomes, C. L.; Messersmith, W. A.

In: Annals of Oncology, Vol. 26, No. 12, 01.12.2015, p. 2505.

Research output: Contribution to journalArticle

O'Neil, BH, Scott, AJ, Ma, WW, Cohen, SJ, Leichman, L, Aisner, DL, Menter, AR, Tejani, MA, Cho, JK, Granfortuna, J, Coveler, L, Olowokure, OO, Baranda, JC, Cusnir, M, Phillip, P, Boles, J, Nazemzadeh, R, Rarick, M, Cohen, DJ, Radford, J, Fehrenbacher, L, Bajaj, R, Bathini, V, Fanta, P, Berlin, J, McRee, AJ, Maguire, R, Wilhelm, F, Maniar, M, Jimeno, A, Gomes, CL & Messersmith, WA 2015, 'A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer [Ann Oncol (2015), 26, 1923-1929]', Annals of Oncology, vol. 26, no. 12, pp. 2505. https://doi.org/10.1093/annonc/mdv477
O'Neil, B. H. ; Scott, A. J. ; Ma, W. W. ; Cohen, S. J. ; Leichman, L. ; Aisner, D. L. ; Menter, A. R. ; Tejani, M. A. ; Cho, J. K. ; Granfortuna, J. ; Coveler, L. ; Olowokure, O. O. ; Baranda, J. C. ; Cusnir, M. ; Phillip, P. ; Boles, J. ; Nazemzadeh, R. ; Rarick, M. ; Cohen, D. J. ; Radford, J. ; Fehrenbacher, L. ; Bajaj, R. ; Bathini, V. ; Fanta, P. ; Berlin, J. ; McRee, A. J. ; Maguire, R. ; Wilhelm, F. ; Maniar, M. ; Jimeno, A. ; Gomes, C. L. ; Messersmith, W. A. / A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer [Ann Oncol (2015), 26, 1923-1929]. In: Annals of Oncology. 2015 ; Vol. 26, No. 12. pp. 2505.
@article{908058c866cc4b7986dc4e63c3ba9456,
title = "A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer [Ann Oncol (2015), 26, 1923-1929]",
author = "O'Neil, {B. H.} and Scott, {A. J.} and Ma, {W. W.} and Cohen, {S. J.} and L. Leichman and Aisner, {D. L.} and Menter, {A. R.} and Tejani, {M. A.} and Cho, {J. K.} and J. Granfortuna and L. Coveler and Olowokure, {O. O.} and Baranda, {J. C.} and M. Cusnir and P. Phillip and J. Boles and R. Nazemzadeh and M. Rarick and Cohen, {D. J.} and J. Radford and L. Fehrenbacher and R. Bajaj and V. Bathini and P. Fanta and J. Berlin and McRee, {A. J.} and R. Maguire and F. Wilhelm and M. Maniar and A. Jimeno and Gomes, {C. L.} and Messersmith, {W. A.}",
year = "2015",
month = "12",
day = "1",
doi = "10.1093/annonc/mdv477",
language = "English (US)",
volume = "26",
pages = "2505",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer [Ann Oncol (2015), 26, 1923-1929]

AU - O'Neil, B. H.

AU - Scott, A. J.

AU - Ma, W. W.

AU - Cohen, S. J.

AU - Leichman, L.

AU - Aisner, D. L.

AU - Menter, A. R.

AU - Tejani, M. A.

AU - Cho, J. K.

AU - Granfortuna, J.

AU - Coveler, L.

AU - Olowokure, O. O.

AU - Baranda, J. C.

AU - Cusnir, M.

AU - Phillip, P.

AU - Boles, J.

AU - Nazemzadeh, R.

AU - Rarick, M.

AU - Cohen, D. J.

AU - Radford, J.

AU - Fehrenbacher, L.

AU - Bajaj, R.

AU - Bathini, V.

AU - Fanta, P.

AU - Berlin, J.

AU - McRee, A. J.

AU - Maguire, R.

AU - Wilhelm, F.

AU - Maniar, M.

AU - Jimeno, A.

AU - Gomes, C. L.

AU - Messersmith, W. A.

PY - 2015/12/1

Y1 - 2015/12/1

UR - http://www.scopus.com/inward/record.url?scp=84949942343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949942343&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdv477

DO - 10.1093/annonc/mdv477

M3 - Article

AN - SCOPUS:84949942343

VL - 26

SP - 2505

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 12

ER -